vidarabine has been researched along with Remission, Spontaneous in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE | 1 |
Adams, HG; Alexander, ER; Benson, EA; Holmes, KK; Remington, MA; Vontver, LA | 1 |
Chastel, C; Colin, J; Le Grignou, A; Renard, G | 1 |
1 trial(s) available for vidarabine and Remission, Spontaneous
Article | Year |
---|---|
Genital herpetic infection in men and women: clinical course and effect of topical application of adenine arabinoside.
Topics: Administration, Topical; Cervix Uteri; Clinical Trials as Topic; Drug Evaluation; Female; Herpes Simplex; Humans; Male; Placebos; Purine Nucleosides; Recurrence; Remission, Spontaneous; Simplexvirus; Vidarabine | 1976 |
2 other study(ies) available for vidarabine and Remission, Spontaneous
Article | Year |
---|---|
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
[Adenine arabinoside in herpes simplex keratitis (author's transl)].
Topics: Drug Evaluation; Drug Resistance, Microbial; Humans; Idoxuridine; Keratitis, Dendritic; Remission, Spontaneous; Vidarabine | 1979 |